This study is in progress, not accepting new patients
Avacincaptad Pegol Open-Label Extension for Patients With Geographic Atrophy
Summary
- Eligibility
- for people ages 50 years and up (full criteria)
- Location
- at UCLA
- Dates
- study startedcompletion around
Description
Summary
Official Title
Keywords
Eligibility
Locations
Details
- Status
- in progress, not accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Astellas Pharma Global Development, Inc.
- ID
- NCT05536297
- Phase
- Phase 3 research study
- Study Type
- Interventional
- Participants
- About 278 people participating
- Last Updated